Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069))
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
239 0
SM ISO690:2012
SCHOLL, Susan Marie E., POPOVIC, Marina, SAMEŢ, Nina. Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069)). In: EBioMedicine, 2020, nr. 57, p. 0. ISSN 2353-3964. DOI: https://doi.org/10.1016/j.ebiom.2020.102875
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
EBioMedicine
Numărul 57 / 2020 / ISSN 2353-3964 /ISSNe 2352-3964

Corrigendum to ‘clinical and genetic landscape of treatment naive cervical cancer: Alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome’ (EBioMedicine (2019) 43 (253–260), (S2352396419302142), (10.1016/j.ebiom.2019.03.069))

DOI: https://doi.org/10.1016/j.ebiom.2020.102875

Pag. 0-0

Scholl Susan Marie E.1, Popovic Marina2, Sameţ Nina3
 
1 Institut Curie,
2 Oncology Institute of Vojvodina Iov,
3 Institute of Oncology
 
Disponibil în IBN: 18 martie 2021


Rezumat

The authors wish to clarify that the authors Aljosa Mandic, Katarina Koprivsek, and Goran Malenkovic are also affiliated with Faculty of Medicine Novi Sad, University of Novi Sad, Serbia, as well as Gynecologic Oncology Department Clinic for Operative Oncology, Institute of Oncology of Vojvodina, Serbia. 

Cuvinte-cheie
erratum